Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies

Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies

Background: Automated insulin delivery (AID) systems have demonstrated improvements in time-in-range (TIR, blood glucose 70-180 mg/dL) without increasing hypoglycemia. Testing a closed-loop system in an inpatient environment with supervised challenges allows for initial evaluation of performance and...

Full description

Bibliographic Details
Main Authors: Bartee, A. (Author), Brazg, R. (Author), Christiansen, M. (Author), Jones, R.E (Author), Katz, M. (Author), Lalonde, A. (Author), Wolpert, H. (Author)
Format: Article
Language:English
Published: Mary Ann Liebert Inc. 2021
Subjects:
adult
Adult
adverse device effect
antidiabetic agent
Article
artificial pancreas
Automated insulin delivery
automation
Blood Glucose
blood glucose monitoring
Blood Glucose Self-Monitoring
carbohydrate
clinical article
clinical assessment
clinical evaluation
controlled study
device safety
Diabetes Mellitus, Type 1
drug delivery system
Early feasibility
exercise
Feasibility Studies
feasibility study
female
Female
glucose
glucose blood level
hospital patient
human
Humans
Hybrid closed loop
hyperglycemia
hypoglycemia
Hypoglycemic Agents
insulin
Insulin
insulin dependent diabetes mellitus
insulin infusion
Insulin Infusion Systems
insulin lispro
male
Male
meal
middle aged
Middle Aged
model predictive control
Pancreas, Artificial
postprandial state
priority journal
self care
short acting insulin
test meal
treatment duration
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items